abstract |
The present invention relates to at least one novel Mut-IL18 or Mut-IL-18R proteins, antibodies, including isolated nucleic acids that encode at least one Mut-IL18 or Mut-IL-18R protein or antibody, Mut-IL18 or Mut-IL-18R vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices. |